SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under
Section 12(g) of the Securities Exchange Act of 1934 or
Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934
Commission File Number
333-166848
Resolute Oncology Inc.
_______________________________________
(Exact name of registrant as specified in its charter)
1200 Route 22 East, Suite 2000, Bridgewater, New Jersey, 08807
Telephone: 908-253-3590
___________________________________________________________
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
common stock, par value $0.001 par value
__________________________________________
(Title of each class of securities covered by this Form)
None
_______________________________________________
(Titles of all other classes of securities for which a duty to file
reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) [ ]
Rule 12g-4(a)(2) [ ]
Rule 12h-3(b)(1)(i) [ ]
Rule 12h-3(b)(1)(ii) [ ]
Rule 15d-6 [x]
Approximate number of holders of record as of the certification or notice date: 45
Pursuant to the requirements of the Securities Exchange Act of 1934, Resolute Oncology Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
June 30, 2014
|
Resolute Oncology Inc.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Blair Sorby
|
|
|
|
|
Blair Sorby
|
|
|
|
|
resident and Chief Executive Officer
|
|
|
|
|
|
|